EUCTR2010-019657-18-AT进行中（未招募）1 期
Topical Imiquimod in Treating Patients with Persistent HPV-Infection after Surgical or Radiation Treatment of Cervical Cancer - TACTIQ (Treatment after Cervical Cancer with topical Imiquimod)-trial
Medizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Gynäkologie und Gyn.Onkologie0 个研究点开始时间: 2010年4月28日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Patient aged 18 years or older after surgical or radiation treatment for cervical cancer
- •positive high risk HPV-test 6 months after treatment
- •signed informed consent
- •negative urine pregnancy test (only applicable for patients after radiation treatment)
- •safe contraception (only applicable for patients after radiation treatment)
- •Able to communicate well with the investigator, to understand and comply with the requirements of the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •History of hypersensitivity to the trial drug or to drugs with a similar chemical structure
- •Participance in another clinical trial within 30 days
- •Immunosuppression (medication, illness)
- •HIV- or Hepatitis infection
- •histologically proven cervical cancer recurrence
研究者
相似试验
进行中（未招募）
1 期
Topical Imiquimod in Treating Patients with Grade 2/3 Cervical Intraepithelial Neoplasia - ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-TrialGrade 2/3 Cervical Intraepithelial NeoplasiaMedDRA version: 9.1Level: LLTClassification code 10049701Term: Cervical intraepithelial neoplasia IIMedDRA version: 9.1Level: LLTClassification code 10049702Term: Cervical intraepithelial neoplasia IIIEUCTR2008-007763-16-ATMedizinische Universität Wien, Univ.Klinik f.Frauenheilkunde,Abt. f.Gynäkologie und Gyn.Onkologie60
尚未招募
3 期
The effect of topical Imiquimod5% in treatment of high-grade cervical neoplasias (CIN2,3)The recovery rate of high-grade cervical neoplasias.IRCT20230811059116N1Iran University of Medical Sciences80
招募中
1 期
Exploratory study of imiquimod topical therapy for Bowen's diseaseBowen diseaseJPRN-jRCTs041230132Yoshikawa Shusuke12
已完成
3 期
The effect of topical piroxicam in the treatment of uremic pruritusPruritusIRCT20191106045356N18Yazd University of Medical Sciences50
招募中
2 期
Topical Imiquimod or Diphenylcyclopropenone for the Management of Cutaneous In-transit Melanoma Metastases – A Phase II Single Centre Prospective Randomised Pilot StudyCutaneous in-transit melanoma metastasesCancer - Malignant melanomaACTRN12615001088538Professor B Mark Smithers30